KORU Medical Systems Inc. (KRMD)
(Delayed Data from NSDQ)
$2.68 USD
0.00 (0.00%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $2.70 +0.02 (0.75%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum B VGM
Price, Consensus and EPS Surprise
KRMD 2.68 0.00(0.00%)
Will KRMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KRMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KRMD
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates
Veracyte (VCYT) Q2 Earnings and Revenues Beat Estimates
KRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
AxoGen (AXGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Will KORU Medical Systems Inc. (KRMD) Report Negative Earnings Next Week? What You Should Know
DexCom (DXCM) Q2 Earnings Surpass Estimates
Other News for KRMD
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference
KORU Medical Systems Inc (KRMD) Q2 2024 Earnings: EPS of $(0.02) Beats Estimates, Revenue of $8. ...
Strong Performance and Promising Prospects Justify Buy Rating for KORU Medical Systems
REPRO-MED Systems: A Buy Rating with Robust Growth and Positive Outlook
REPRO-MED Systems (KRMD) Receives a Buy from Piper Sandler